Clinical relevance of the comparative expression of immune checkpoint markers with the clinicopathological findings in patients with primary and chemoreduced retinoblastoma

Singh, Lata ; Singh, Mithalesh Kumar ; Rizvi, Moshahid Alam ; Bakhshi, Sameer ; Meel, Rachna ; Lomi, Neiwete ; Sen, Seema ; Kashyap, Seema (2020) Clinical relevance of the comparative expression of immune checkpoint markers with the clinicopathological findings in patients with primary and chemoreduced retinoblastoma Cancer Immunology, Immunotherapy, 69 (6). pp. 1087-1099. ISSN 0340-7004

Full text not available from this repository.

Official URL: https://doi.org/10.1007/s00262-020-02529-4

Related URL: http://dx.doi.org/10.1007/s00262-020-02529-4

Abstract

The goal of this study is to identify the pathological findings and expression of immune checkpoint marker (PD-1, PD-L1, and CTLA-4) in the tumor microenvironment of both primary and chemoreduced retinoblastoma and correlate them with clinicopathological parameters and patient outcome.

Item Type:Article
Source:Copyright of this article belongs to Springer-Verlag.
ID Code:137925
Deposited On:18 Aug 2025 12:53
Last Modified:18 Aug 2025 12:53

Repository Staff Only: item control page